Antigen Identification in Membranous Nephropathy Moves toward Targeted Monitoring and New Therapy
Authors:
- Pierre RoncoPRPierre Ronco
- Hanna DebiecHDHanna Debiec
- 1 April 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (4) , 564-569
Abstract
Membranous nephropathy, a disease characterized by an accumulation of immune deposits on the outer aspect of the glomerular basement membrane, is the most common cause of idiopathic nephrotic syndrome in Caucasian adults. In the rat model described by Heymann in 1959, the target antigen of antibodies is megalin, a multiligand receptor expressed in the rat glomerulus but absent from the human glomerulus. In the past few years, two major antigens have been identified in human membranous nephropathy. The first is neutral endopeptidase, the alloantigen involved in neonatal cases of membranous nephropathy that occur in newborns from neutral endopeptidase-deficient mothers. The second is the type-M phospholipase A2 receptor (PLA2R), the first autoantigen identified in idiopathic membranous nephropathy in the adult. Megalin, neutral endopeptidase, and PLA2R are all expressed on the podocyte surface where they serve as targets for circulating antibodies, which lead to in situ immune complex formation, complement activation, and proteinuria. The recent discovery of neutral endopeptidase and PLA2R provides new tools for monitoring human disease activity and should be of value in designing new antigen-driven therapeutic strategies.Keywords
This publication has 37 references indexed in Scilit:
- Controversies in the treatment of idiopathic membranous nephropathyNature Reviews Nephrology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Mucosal Tolerance Induced by an Immunodominant Peptide from Rat α3(IV)NC1 in Established Experimental Autoimmune GlomerulonephritisThe American Journal of Pathology, 2009
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent PatientsClinical Journal of the American Society of Nephrology, 2009
- Rituximab Therapy for Membranous NephropathyClinical Journal of the American Society of Nephrology, 2009
- Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisNature Medicine, 2008
- Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2008
- Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosisArthritis Research & Therapy, 2008
- Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoringPediatric Nephrology, 2006
- Molecular Pathomechanisms of Membranous NephropathyJournal of the American Society of Nephrology, 2005